Carl Goldfischer, Director at CymaBay Therapeutics, Inc. (CBAY), sold 15,000 shares at $13.03 ($195K) on 2018-03-22, disclosed to the SEC on 2018-03-23.
Open-market sale of $195k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CBAY | SELL | 2017-11-06 | $156K | — | Filing → |
| ETRM | SELL | 2017-05-31 | $23K | — | Filing → |
| EPZM | BUY | 2016-01-12 | $5.0M | — | Filing → |